Literature DB >> 15294260

Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms.

Jean-Jacques Blanc1, Luc De Roy, Jacques Mansourati, Yann Poezevara, Jean-Louis Marcon, Wolfgang Schoels, Françoise Hidden-Lucet, Claude Barnay.   

Abstract

AIMS: Several preliminary studies indicated that right atrial pacing could prevent atrial tachyarrhythmias (ATA). We sought to compare the safety and the efficacy of atrial-based pacing supplemented by dedicated combined algorithms with conventional atrial pacing in the prevention of ATA.
METHODS: Fifty-five patients with a history of recurrent paroxysmal ATA implanted with a dual-chamber pacemaker were studied during two randomized cross-over pacing periods (conventional DDD and DDD with ATA prevention algorithms) of 6 months duration. The primary endpoint was the burden of ATA episodes recorded by the device mode switch algorithm.
RESULTS: The cross-over analysis did not demonstrate any significant difference between the two pacing modes: 254+/-533 h of ATA during the control period versus 238+/-518 h during the ATA prevention period. Analysis of a subgroup of patients found that those with the lower percentage of ventricular pacing benefited from ATA prevention algorithms (120+/-182 h versus 225+/-350 h during the control period; P < 0.04).
CONCLUSION: When compared with DDD pacing at 70 bpm, ATA prevention algorithms have not demonstrated significant efficacy. However, a subgroup of patients with preserved native AV conduction (low percentage of ventricular pacing) responded to ATA prevention algorithms.

Entities:  

Mesh:

Year:  2004        PMID: 15294260     DOI: 10.1016/j.eupc.2004.05.002

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  15 in total

Review 1.  Management of atrial fibrillation--what are the possibilities of early detection with home monitoring?

Authors:  R P Ricci; M Russo; M Santini
Journal:  Clin Res Cardiol       Date:  2006       Impact factor: 5.460

2.  [The role of cardiac pacing in atrial arrhythmia prevention].

Authors:  G Fröhlig
Journal:  Z Kardiol       Date:  2005

Review 3.  Management of atrial fibrillation in bradyarrhythmias.

Authors:  Giuseppe Boriani; Luigi Padeletti
Journal:  Nat Rev Cardiol       Date:  2015-03-17       Impact factor: 32.419

Review 4.  Homogenization of Atrial Electrical Activities: Conceptual Restoration of Regional Electrophysiological Parameters to Deter Ischemia-Dependent Conflictogenic Atrial Fibrillation.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 5.  Controversies in pacing: indications and programming.

Authors:  Anne M Gillis; Rik Willems
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

6.  The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: the 'MinVPace' study.

Authors:  Rick A Veasey; Anita Arya; Nick Freemantle; John Silberbauer; Nikhil R Patel; Guy W Lloyd; A Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2010-01-16       Impact factor: 1.900

7.  [Atrial pacing for prevention of atrial fibrillation. Influence of septal atrial pacing, atrial overdrive and AV-delay-optimization on atrial fibrillation burden].

Authors:  M Klein; N Klein; D Pfeiffer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-09

8.  Non-physiological increase of AV conduction time in sinus disease patients programmed in AAIR-based pacing mode.

Authors:  Philippe Mabo; Jean-Pierre Cebron; Aude Solnon; Aude Tassin; Laurence Graindorge; Daniel Gras
Journal:  J Interv Card Electrophysiol       Date:  2012-07-27       Impact factor: 1.900

9.  [Sandwiched between the single- and triple-chamber ICD: do we still need the dual-chamber ICD?].

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-12

10.  Atrial overdrive pacing and incidence of heart failure-related adverse events in permanently paced patients.

Authors:  Andreas Schuchert; Mark Carlson; John Ip; John Messenger; Scott Beau; Steven Kalbfleisch; Pierre Gervais; Douglas A Cameron; Aurelio Duran; Jesus Val-Mejias; Judith Mackall; Michael Gold
Journal:  J Interv Card Electrophysiol       Date:  2007-06-29       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.